---
document_datetime: 2023-09-21 18:32:23
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/cuprymina-epar-all-authorised-presentations_en.pdf
document_name: cuprymina-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.4559459
conversion_datetime: 2025-12-14 13:22:07.147674
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form                     | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size   |
|------------------|-------------------|------------|-----------------------------------------|---------------------------|-----------------------|---------------------------|-------------|
| EU/1/12/784/001  | Cuprymina         | 925 MBq/ml | Radiopharmaceutical precursor, solution |                           | vial (glass)          | 1 to 3 ml                 | 1 vial      |